Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€153.75

€153.75

0.360%
0.55
0.360%
€171.48

€171.48

 
13.03.26 / Tradegate WKN: 578074 / Symbol: MASI / Name: Masimo / Stock / Healthcare Equipment & Supplies / Mid Cap /
Latest predictions
€171.48
04.12.25
32.83%
buy
€172.00
24.11.25
20.57%
buy
€162.71
05.11.25
24.75%
buy
€172.28
05.11.25
24.14%
buy
28.09.25
26.89%
buy
€169.25
11.09.25
22.72%
buy
Best running prediction
€171.48
04.12.25
32.83%
buy
Your prediction

Masimo Corp. Stock

Masimo Corp. gained 0.360% compared to yesterday.
Masimo Corp. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
As a result the target price of 171 € shows a slightly positive potential of 11.22% compared to the current price of 153.75 € for Masimo Corp..

Pros and Cons of Masimo Corp. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Masimo Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Masimo Corp. 0.360% 1.687% 35.105% 0.853% 38.264% -7.602% -21.954%
Neogen Corp. -3.070% -4.762% -11.602% -4.192% 30.081% - -
CONMED Corp. 1.890% -6.358% -7.429% -39.439% -7.429% -62.543% -68.846%
Bio-Techne Corp. 1.790% -10.442% -18.165% -19.640% -10.800% -35.362% -

Comments

Prediction Buy
Perf. (%) 32.83%
Target price 171.480
Change
Ends at 04.12.26

Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for MASI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 20.57%
Target price 172.003
Change
Ends at 24.11.26

Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Ratings data for MASI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 24.75%
Target price 162.709
Change
Ends at 05.11.26

Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Ratings data for MASI provided by MarketBeat
Show more

News

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement: https://cdn.content.foolcdn.com/images/1umn9qeh/production/37a7f80f063688ddbd3b84d74a534e9e7a0367b6-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement

On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at

Naya Capital Adds Masimo Shares: https://cdn.content.foolcdn.com/images/1umn9qeh/production/f5acfa2370b69ef05efd688fbbc9e56e546c0092-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Naya Capital Adds Masimo Shares

According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.

Masimo is a leading provider of

4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares

On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo (NASDAQ:MASI). The sale was valued at $7.57 million.

According to a filing with the